UK-US Pharma Deal Lacks Legal Text, MPs Warn
MPs warn UK's zero-tariff pharmaceutical deal with the Trump administration is 'built on sand' as no legal text exists. Concerns mount over NHS costs and suspended tech pact. Read the full analysis.
Category : Search result: pharmaceutical deal
NHS to pay £1bn more for drugs under US trade deal
The NHS must find an extra £1bn annually for medicines under a new US trade pact, with no new Treasury funding. Health leaders warn of frontline service cuts. Read the full analysis.
NHS Trump drug deal 'may cost 15,000 lives'
A £3bn deal to pay US drug firms more and avoid Trump's tariffs could lead to 15,971 extra deaths yearly as NHS rations care, York University research reveals. Read the full analysis.
UK-US Agree Zero Tariff Deal on Medicines
The UK and US have agreed a three-year deal to maintain 0% tariffs on pharmaceuticals, aiming to boost trade and secure NHS access to new treatments. Read the full details.
UK-US strike tariff deal on pharmaceuticals
The UK and US agree a major trade deal removing US import taxes on UK drugs for 3 years, while the NHS commits to higher spending on new medicines. Discover the impact.
UK-US agree zero tariff deal on pharmaceuticals
The UK and US have struck a deal to maintain 0% tariffs on medicines for three years, alongside NHS commitments to increase spending on new drugs. Discover the implications for patients and industry.
UK-US Agree Zero-Tariff Pharmaceuticals Deal
The UK and US have finalised a landmark trade agreement to eliminate tariffs on pharmaceutical products. Discover how this deal aims to lower drug costs and boost medical innovation.
NHS drug costs to rise 25% in US trade deal
The NHS will pay 25% more for new medicines under a UK-US trade agreement, costing taxpayers £3bn. The deal secures zero tariffs for UK pharmaceutical exports to America. Discover the full impact.
UK and US agree zero tariff deal on medicines
The UK and US have agreed a three-year deal to maintain 0% import tariffs on pharmaceuticals, aiming to secure NHS access to cutting-edge treatments and boost investment. Read the full details.
UK-US set for zero-tariff pharma deal amid NHS price row
The UK is poised to strike a deal with the US removing tariffs on pharmaceuticals, following warnings of investment cuts. The agreement hinges on the NHS paying more for American medicines. Read the full details.
ADHD medication recalled over effectiveness issues
A popular generic ADHD medication is being recalled nationwide after tests showed it may not dissolve properly, failing to deliver the full dose. Patients urged to check their prescriptions.
Big Pharma's Tax Breaks: Calls for Transparency Grow
Pharmaceutical giants face mounting pressure to justify massive tax incentives amid concerns over NHS funding and pandemic-era profit surges. Westminster demands clarity on whether public investment delivers fair returns.
UK patients face treatment delays in pharma pricing crisis
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
Pharmacy Visionary Robert Wilkinson Dies at 86
Tributes pour in for pioneering pharmacist Robert Wilkinson, whose groundbreaking work revolutionised NHS patient care and established new standards for community pharmacy across Britain.
GSK chief warns UK drug pricing reforms threaten industry
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
GSK shares tumble nearly 10% on HIV drug trial results
Pharmaceutical giant GSK faces significant market pressure as its experimental HIV prevention drug shows mixed results in clinical trials, sending shares tumbling nearly 10%.
UK productivity downgrade sparks tax rise fears
Britain faces a stark economic reckoning as official forecasts slash productivity growth, triggering speculation about imminent tax rises while major corporations voice concerns over investment climate.
Major Statin Recall: 140,000 Bottles Withdrawn
Urgent medication safety warning as cholesterol drug Atorvastatin faces massive recall over contamination fears. FDA investigation reveals critical manufacturing issues.
New Alzheimer's Drug Slows Brain Decline in Trial
A pioneering new treatment has demonstrated remarkable success in slowing memory loss and cognitive decline in Alzheimer's patients, offering fresh hope for millions affected by the devastating condition.
NHS patients denied vital medications in supply crisis
Exclusive investigation reveals how NHS patients across Britain are being denied essential medicines due to catastrophic supply chain failures, with government accused of prioritising pharmaceutical profits over public health.
Novo Nordisk Board Exodus: Chairman & 6 Directors Depart
Danish pharmaceutical giant Novo Nordisk faces major leadership shakeup as chairman and six board members step down following unprecedented growth of weight-loss drug Wegovy.
Moderna's Oxfordshire vaccine centre gets green light
In a landmark development for UK life sciences, Moderna's cutting-edge mRNA vaccine research centre is coming to Oxfordshire, creating hundreds of jobs and cementing Britain's position in global healthcare innovation.
Trump's Ozempic Remark Hits Pharma Stocks
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Trump's Ozempic Price Pledge Shakes Pharma Markets
Former President Donald Trump pledges to slash prices of weight-loss drugs Ozempic and Wegovy, sending pharmaceutical stocks tumbling and sparking healthcare debate.
California declares emergency over insulin prices
Governor Gavin Newsom takes unprecedented action against pharmaceutical giants as insulin prices soar, making California first US state to produce its own affordable medication.
Trump's FDA Win: IVF Drug Approved Despite Opposition
In a significant political victory, Donald Trump secures FDA approval for Washington's IVF medication, overcoming fierce opposition and setting new healthcare precedents.
New weight loss jab shows unprecedented 24% reduction
Breakthrough drug Retatrutide demonstrates remarkable 24% weight loss in clinical trials, potentially revolutionising obesity treatment in the UK healthcare landscape.
J&J Pays $700M in Talc Cancer Scandal Settlement
Pharmaceutical giant Johnson & Johnson agrees to pay $700 million settlement amid allegations their talcum powder contained asbestos and caused ovarian cancer in thousands of women.
Johnson & Johnson Faces UK Lawsuit Over Talc Cancer Claims
Global pharmaceutical giant Johnson & Johnson is confronting a major class action lawsuit in the UK, with dozens of women alleging its talc-based products caused their cancers. The legal battle could set a crucial precedent for consumer safety.
Johnson & Johnson £50B talc cancer settlement
Pharmaceutical giant Johnson & Johnson agrees to pay £50 billion to settle claims its talcum powder caused cancer, while continuing to deny product safety concerns.
Page 1 of 4